Questionnaire Administration + Dordaviprone + Paclitaxel for fallopian tube neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Aug 2019: Trial registered, NCT04055649
  2. 21 Jan 2020: Trial started, NCT04055649

The trials

NCT04055649: ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer

State
Under way
Phase
Phase 2
People
62 planned
Started
21 Jan 2020
Primary completion
28 May 2027
Arms
Treatment - ONC201 & Paclitaxel
Results
None posted
  1. 14 Aug 2019: Trial registered
  2. 21 Jan 2020: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.